Free Trial
→ When This Happens, You Don’t Wait. You Act. (From Crypto Swap Profits) (Ad) Buy FDMT Stock  Free FDMT Stock Alerts

4D Molecular Therapeutics (FDMT) SEC Filings & 10K Form

4D Molecular Therapeutics logo
$4.07 -0.01 (-0.25%)
Closing price 04:00 PM Eastern
Extended Trading
$4.04 -0.03 (-0.74%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent 4D Molecular Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/15/2025
4:44 PM		4D Molecular Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
05/08/2025
3:33 PM		4D Molecular Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/29/2025
3:10 PM		4D Molecular Therapeutics (Filer)
Form ARS
03/24/2025
11:15 PM		4D Molecular Therapeutics (Filer)
Form EFFECT
03/10/2025
6:56 PM		4D Molecular Therapeutics (Issuer)
Kamal Fariborz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:57 PM		4D Molecular Therapeutics (Issuer)
Mehra Uneek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:58 PM		4D Molecular Therapeutics (Issuer)
Kim Robert Young (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
6:58 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:00 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:57 PM		4D Molecular Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
4:07 PM		4D Molecular Therapeutics (Filer)
Form POS AM
02/14/2025
5:30 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
5:09 PM		4D Molecular Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:34 AM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:40 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SCHEDULE 13G/A
02/10/2025
4:28 PM		4D Molecular Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
7:37 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:36 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:15 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:05 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:15 PM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
8:13 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/13/2024
3:33 PM		4D Molecular Therapeutics (Issuer)
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:17 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:08 PM		4D Molecular Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
11/12/2024
11:12 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
1:17 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
11/06/2024
5:07 PM		4D Molecular Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G
11/04/2024
9:55 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/21/2024
3:11 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
09/18/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:06 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:22 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:13 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:17 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
4:11 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM		4D Molecular Therapeutics (Subject)
Bizily Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
06/26/2024
4:07 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:FDMT) was last updated on 6/26/2025 by MarketBeat.com Staff
From Our Partners
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored
Why July is critical for your stocks
Big Study Shows Stocks Extremely Likely to Crash in 2026? Legendary quant analyst Marc Chaikin says in 50 y...
Chaikin Analytics | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Trump: "Buy Stocks Now!" (Here's a Better Move)
Trump: "Buy Stocks Now!" (Here's a Better Move) President Trump just announced from the Oval Office: "You b...
Investors Alley | Sponsored
OSZAR »